Top Nav Menu

Navigation

DOT Random Drug and Alcohol Testing Rates 2025

DOT Random Drug and Alcohol Testing Rates 2025

Department of Transportation random selection testing rates for drug and alcohol are:

FMCSA:

50% drug / 10% alcohol

FAA:

25% drug / 10% alcohol

PHMSHA:

50% drug (increased from 2024) / N/A alcohol

FTA

50% Drug / 10% Alcohol

FRA

Covered service & MOW employees 25% for drugs and 10% for alcohol.

MECH employees 50% drug / 25% alcohol.

Sources:

 FMCSA: https://iprospectcheck.com/dot-drug-test/

FRA: https://www.transportation.gov/regulations/federal-register-documents/2024-31582

FAA: https://www.federalregister.gov/documents/2024/11/04/2024-25569/random-drug-and-alcohol-testing-percentage-rates-of-covered-aviation-employees-for-the-period-of

PHMSHA: https://www.federalregister.gov/documents/2024/11/20/2024-26737/pipeline-safety-random-drug-testing-rate-multi-factor-authentication-and-operator-and-contractor

FTA: https://www.federalregister.gov/documents/2024/11/26/2024-27646/prevention-of-alcohol-misuse-and-prohibited-drug-use-in-transit-operations

AtHandTraining.com provides online DOT reasonable suspicion drug and alcohol training for FMSCA, FTA, FAA, PHMSHA (not FRA). For the best price in the industry! Bulk pricing available for larger organizations. LMS/Scorm/xAPI supported.  Click here for more info.

Workforce Drug Test Cheating Increased in 2023

Original article link (5-15-2024)

A recent Quest Diagnostics analysis of 9.8 million workforce drug tests for 2023 indicates a massive increase in drug test tampering and elevated positivity rates. The report states…

“The increasing rates of substituted or invalid specimens coincide with historically high rates of both general U.S. workforce drug positivity and post-accident marijuana positivity. Drug positivity in the general U.S. workforce was 5.7% in both 2022 and 2023. In 2023, in the combined U.S. workforce, urine drug positivity for all drugs was 4.6%, the same as in 2021 and 2022. This overall positivity is the highest level in more than two decades, up more than 30% from an all-time low of 3.5% in 2010-2012, and coincides with a sharp increase of 114.3% in post-accident positivity between 2015 and 2023 in the general U.S. workforce.”

 

“The increased rate of both substituted and invalid specimens indicates that some American workers are going to great lengths to attempt to subvert the drug testing process,” said Suhash Harwani, Ph.D., Senior Director of Science for Workforce Health Solutions at Quest Diagnostics. “Given the growing acceptance and use of some drugs, particularly marijuana, it may be unsurprising that some people feel it necessary to try and cheat a drug test. It is possible that our society’s normalization of drug use is fostering environments in which some employees feel it is acceptable to use such drugs without truly understanding the impact they have on workplace safety.”

Other report highlights:

  • Drug test tampering (indicated by substituted or invalid urine specimens) in the general U.S. workforce significantly increased in 2023 (633% for substituted and 45% for invalid).
  • Overall drug test positivity rate in the general U.S. workforce remained high (5.7% in 2023) and marijuana positivity specifically is on an upward trend (4.7% increase in 2023).
  • There’s a concern that increased drug use might be linked to a rise in workplace accidents.
  • The federally mandated safety-sensitive workforce has a lower drug positivity rate, possibly due to deterrence from drug testing.
  • The report suggests a possible link between the pandemic, remote work, and increased drug use among office workers.

Have your supervisors been trained to spot the signs or symptoms of drug or alcohol abuse in the workplace? The D.O.T. requires reasonable suspicion supervisor training for any person authorized to initiate a for-cause drug or alcohol test. Not conducting this training is a violation of federal law for Federal Motor Carrier (FMCSA). Federal Transit FTA), Federal Aviation (FAA), Pipeline and Hazardous Materials (PHMSA) and Federal Railroad (FRA) covered organizations.

AtHandTraining provides 24/7 online training that can be completed in two-hours and provides a certificate of completion. Pricing is only $37 per employee or lower for bulk purchases. 

 

Courses home page link here.

DEA Likely to Reschedule Marijuana Based on Congressional Report

DEA Likely to Reschedule Marijuana Based on Congressional Report

According to a report from the Congressional Research Service (the Report), the Drug Enforcement Administration (DEA) is likely to follow the Department of Health and Human Services (HHS) and the Food and Drug Administration’s (FDA) recommendation to move marijuana from Schedule I to Schedule III under the Controlled Substances Act (CSA). According to the Report, the DEA confirmed in a 2020 congressional hearing that it will be bound by the FDA’s recommendation, “and if past is prologue, it could be likely that DEA will reschedule marijuana according to HHS’s recommendation.” The FDA operates under the umbrella of the HHS, so the Report interchanges references to whether the recommendation comes from the HHS or the FDA.

In October, President Biden requested that the DOJ and the HHS evaluate marijuana’s status as a Schedule I substance under the CSA. Schedule III substances are considered to have an accepted medical use and a relatively lower potential for abuse compared to Schedule I and II substances. 

If Congress removed marijuana from Schedule I, it might place marijuana on one of the other schedules of controlled substances, create another schedule or separate classification for marijuana under the CSA, or remove marijuana as a controlled substance altogether.

Purchase DOT Reasonable Suspicion Training or 

DOT Employee Drug/Alcohol Awareness right now! 

Online 24/7 access!

credit cards accepted


Click Here To Buy DOT Supervisor Course – $37 or less!

Click Here To Buy DOT Employee Drug Awareness Course – $12 or less!